Meet The Artificial Intelligence (AI) Company That Nvidia Is Investing In
https://www.fool.com/investing/2024/03/24/meet-the-artificial-intelligence-ai-company-that-n/?source=iedfolrf0000001
Mar 24, 2024 - SoundHound AI's stock has been on fire recently.
0
Meet the 4 Worst-Performing Dow Stocks in 2024 (and It Could Get Worse Before It Gets Better)
https://www.fool.com/investing/2024/03/24/meet-the-4-worst-performing-dow-stocks-in-2024/?source=iedfolrf0000001
Mar 24, 2024 - Boeing, Intel, Nike, and Apple are all down big this year, for mostly good reasons.
0
Bayer's (BAYRY) Elinzanetant Meets Goals in Third Phase III Study
https://www.zacks.com/stock/news/2243694/bayer-s-bayry-elinzanetant-meets-goals-in-third-phase-iii-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2243694
Mar 20, 2024 - Bayer's (BAYRY) pipeline candidate, elinzanetant, achieves primary and secondary goals in late-stage OASIS 3 study supporting submissions for marketing authorization.
0
Markets Looking Ahead To Central Bank Policy Meetings For Direction
https://www.rttnews.com/story.aspx?Id=3433190
Mar 19, 2024 - The Federal Reserve's two-day monetary policy meeting gets underway today. The Central bank is widely expected to hold interest rates unchanged, and the focus is going to be on the accompanying statement for clues about when the bank will likely start reducing rates.
0
Time is running out for interest rate cuts, market forecaster Jim Bianco warns before Fed meeting
https://www.cnbc.com/2024/03/18/time-running-out-for-rate-cuts-jim-bianco-warns-before-fed-meeting.html
Mar 18, 2024 - "I'm in the camp that the Fed does not change policy in the summer of an election year," the Bianco Research president told CNBC's "Fast Money" on Monday.
0
Inventiva Phase 2 study for MASH drug meets primary endpoint
https://seekingalpha.com/news/4080815-inventiva-phase-2-study-for-mash-drug-meets-primary-endpoint?source=feed_sector_healthcare
Mar 18, 2024 - Inventiva (IVA) reported a Phase 2 study of its drug lanifibranor met its primary efficacy endpoint in the treatment of patients with MASH/NASH and type 2 diabetes. Read more here.
0
Tech Stocks Leading Rebound On Wall Street Ahead Of Fed Meeting
https://www.rttnews.com/story.aspx?Id=3432934
Mar 18, 2024 - Stocks have shown a strong move to the upside during trading on Monday, regaining ground after trending lower over the past few sessions. The major averages have all moved higher, with the tech-heavy Nasdaq leading the advance. Currently, the major averages are hovering near their best levels of the day.
0
Fed Meeting In Focus Amid Uncertainty About Interest Rate Outlook
https://www.rttnews.com/3432903/fed-meeting-in-focus-amid-uncertainty-about-interest-rate-outlook.aspx?type=alleco
Mar 18, 2024 - The Federal Reserve's monetary policy meeting will be it the spotlight this week, with the central bank due to announce its latest interest rate decision on Wednesday. The Fed is widely expected to leave interest rates unchanged, but the accompanying statement and economic projections could have a significant impact on the outlook for rates.
0
Three track and field athletes win two events, set two meet records at Laguna Beach meet
https://www.ocregister.com/2024/03/17/three-track-and-field-athletes-win-two-events-set-two-meet-records-at-laguna-beach-meet/
Mar 17, 2024 - Jack Horrocks, Zach Lewis and Ava Simos shine at Laguna Beach Trophy Invitational track meet
0
Meet the Most Innovative "Magnificent Seven" Stock, According to This Key Metric
https://www.fool.com/investing/2024/03/17/meet-the-most-innovative-magnificent-seven-stock/?source=iedfolrf0000001
Mar 17, 2024 - Meta Platforms is now a mature business that can directly reward shareholders without compromising its long-term growth.
0